4 unchanged sentences
Amended and Restated Bylaws
−Removed: Fifth Amendment Dated April 1, 2021 to the Lease agreement dated September 30, 2015 between Arcus Biosciences, Inc.
−Removed: and Hayward Point Eden I Limited Partnership.
−Removed: Third Amendment dated May 10, 2021 to the License Agreement dated August 16, 2017 between Arcus Biosciences, Inc.
−Removed: and WuXi Biologics Ireland Limited.
Separation and Consulting Agreement by and between the Company and William Grossman dated July 16, 2021.
−Removed: Non-Employee Director Compensation Program
+Added: August 5, 2021
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+Added: XBRL Instance Document –
+Added: The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
Inline XBRL Taxonomy Extension Schema Document
5 unchanged sentences
* Filed herewith.
−Removed: Certain information has been omitted because it is both not material and is the type of information that the Registrant treats as private or confidential.
−Removed: This certification is deemed not filed for purposes of section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
+Added: This certification is deemed furnished but not filed for purposes of section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ARCUS BIOSCIENCES, INC.
−Removed: August 5, 2021
+Added: November 8, 2021
/s/ Terry Rosen
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 5, 2021
+Added: November 8, 2021
/s/ Robert C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.